Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 41.

Stenzel, W; Preusse, C; Allenbach, Y; Pehl, D; Junckerstorff, R; Heppner, F L; Nolte, K; Aronica, E; Kana, V; Rushing, E; Schneider, U; Claeys, K G; Benveniste, O; Weis, J; Goebel, H H (2015). Nuclear actin aggregation is a hallmark of anti-synthetase syndrome-induced dysimmune myopathy. Neurology, 84(13):1346-1354.

Bady, P; Sciuscio, D; Diserens, A C; Bloch, J; van den Bent, M J; Marosi, C; Dietrich, P Y; Weller, M; Mariani, L; Heppner, F L; Macdonald, D R; Lacombe, D; Stupp, R; Delorenzi, M; Hegi, M E (2013). Erratum to: MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status. Acta Neuropathologica, 126(1):159.

Bady, P; Sciuscio, D; Diserens, A C; Bloch, J; van den Bent, M J; Marosi, C; Dietrich, P Y; Weller, M; Mariani, L; Heppner, F L; McDonald, D R; Lacombe, D; Stupp, R; Delorenzi, M; Hegi, M E (2012). MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status. Acta Neuropathologica, 124(4):547-560.

Hegi, M E; Diserens, A C; Bady, P; Kamoshima, Y; Kouwenhoven, M C; Delorenzi, M; Lambiv, W L; Hamou, M F; Matter, M S; Koch, A; Heppner, F L; Yonekawa, Y; Merlo, A; Frei, K; Mariani, L; Hofer, S (2011). Pathway analysis of glioblastoma tissue after preoperative treatment with the EGFR tyrosine kinase inhibitor gefitinib - a phase II trial. Molecular Cancer Therapeutics, 10(6):1102-1112.

Sutter, R; Shakhova, O; Bhagat, H; Behesti, H; Sutter, C; Penkar, S; Santuccione, A; Bernays, R L; Heppner, F L; Schüller, U; Grotzer, M; Moch, H; Schrami, P; Marino, S (2010). Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas. Oncogene, 29(12):1845-1856.

Kaffenberger, T; Valko, P O; von Meyenburg, J; Baráth, K; Hewer, E; Heppner, F L; Jagella, C E; Horst, A; Siccoli, M M (2009). A case of late onset leukoencephalopathy with cerebral calcifications and cysts in a 59-year-old woman. European Journal of Neurology, 16(2):278-281.

Schreiner, B; Heppner, F L; Becher, B (2009). Modeling multiple sclerosis in laboratory animals. Seminars in Immunopathology, 31(4):479-495.

Kuehnle, K; Ledesma, M D; Kalvodova, L; Smith, A E; Crameri, A; Skaanes-Brunner, F; Thelen, K M; Kulic, L; Lütjohann, D; Heppner, F L; Nitsch, R M; Mohajeri, M H (2009). Age-dependent increase in desmosterol restores DRM formation and membrane-related functions in cholesterol-free DHCR24(-/-) mice. Neurochemical Research (34, 1167-82). Neurochemical Research, 34(8):1522.

Grathwohl, S A; Kälin, R E; Bolmont, T; Prokop, S; Winkelmann, G; Kaeser, S A; Odenthal, J; Radde, R; Eldh, T; Gandy, S; Aguzzi, A; Staufenbiel, M; Mathews, P M; Wolburg, H; Heppner, F L; Jucker, M (2009). Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia. Nature Neuroscience, 12(11):1361-1363.

Ingold, B; Schraml, P; Heppner, F L; Moch, H (2009). Homogeneous MGMT immunoreactivity correlates with an unmethylated MGMT promoter status in brain metastases of various solid tumors. PLoS ONE, 4(3):e4775.

Haak, S; Croxford, A L; Kreymborg, K; Heppner, F L; Pouly, S; Becher, B; Waisman, A (2009). IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. Journal of Clinical Investigation, 119(1):61-69.

Aslund, A; Sigurdson, C J; Klingstedt, T; Grathwohl, S; Bolmont, T; Dickstein, D L; Glimsdal, E; Prokop, S; Lindgren, M; Konradsson, P; Holtzman, D M; Hof, P R; Heppner, F L; Gandy, S; Jucker, M; Aguzzi, A; Hammarström, P; Nilsson, K P R (2009). Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses. ACS Chemical Biology, 4(8):673-684.

Steele, A D; Hutter, G; Jackson, W S; Heppner, F L; Borkowski, A W; King, O D; Raymond, G J; Aguzzi, A; Lindquist, S (2008). Heat shock factor 1 regulates lifespan as distinct from disease onset in prion disease. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 105(36):13626-13631.

Falsig, J; Julius, C; Margalith, I; Schwarz, P; Heppner, F L; Aguzzi, A (2008). A versatile prion replication assay in organotypic brain slices. Nature Neuroscience, 11(1):109-117.

Kuehnle, K; Crameri, A; Kälin, R E; Luciani, P; Benvenuti, S; Peri, A; Ratti, F; Rodolfo, M; Kulic, L; Heppner, F L; Nitsch, R M; Mohajeri, M H (2008). Prosurvival effect of DHCR24/Seladin-1 in acute and chronic responses to oxidative stress. Molecular and Cellular Biology, 28(2):539-550.

Ingold, B; Wild, P J; Nocito, A; Amin, M B; Storz, M; Heppner, F L; Moch, H (2008). Renal cell carcinoma marker reliably discriminates central nervous system haemangioblastoma from brain metastases of renal cell carcinoma. Histopathology, 52(6):674-681.

Gianella, S; Schaer, D J; Schwarz, U; Kurrer, M; Heppner, F L; Fehr, J; Seebach, J D (2008). Retinal microangiopathy and rapidly fatal cerebral edema in a patient with adult-onset Still's disease and concurrent macrophage activation syndrome. American Journal of Hematology, 83(5):424-427.

Priller, J; Prinz, M; Heikenwalder, M J; Zeller, N; Schwarz, P; Heppner, F L; Aguzzi, A (2006). Early and rapid engraftment of bone marrow-derived microglia in scrapie. Journal of Neuroscience, 26(45):11753-11762.

Donofrio, G; Heppner, F L; Polymenidou, M; Musahl, C; Aguzzi, A (2005). Paracrine inhibition of prion propagation by anti-PrP single-chain Fv miniantibodies. Journal of Virology, 79(13):8330-8338.

Nikles, D; Bach, P; Boller, K; Merten, C A; Montrasio, F; Heppner, F L; Aguzzi, A; Cichutek, K; Kalinke, U; Buchholz, C J (2005). Circumventing tolerance to the prion protein (PrP): vaccination with PrP-displaying retrovirus particles induces humoral immune responses against the native form of cellular PrP. Journal of Virology, 79(7):4033-4042.

Heppner, F L; Greter, M; Marino, D; Falsig, J; Raivich, G; Hövelmeyer, N; Waisman, A; Rülicke, T; Prinz, M; Priller, J; Becher, B; Aguzzi, A (2005). Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nature Medicine, 11(2):146-152.

Polymenidou, M; Heppner, F L; Pellicioli, E C; Urich, E; Miele, G; Braun, N; Wopfner, F; Schätzl, H M; Becher, B; Aguzzi, A (2004). Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 101(S2):14670-14676.

Heppner, F L; Aguzzi, A (2004). Recent developments in prion immunotherapy. Current Opinion in Immunology, 16(5):594-598.

Genoud, Nicolas; Behrens, A; Miele, G; Robay, D; Heppner, F L; Freigang, S; Aguzzi, A (2004). Disruption of Doppel prevents neurodegeneration in mice with extensive Prnp deletions. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 101(12):4198-4203.

Gandy, S; DeMattos, R B; Lemere, C A; Heppner, F L; Leverone, J; Aguzzi, A; Ershler, W B; Dai, J; Fraser, P; St George Hyslop, P; Holtzman, D M; Walker, L C; Keller, E T (2004). Alzheimer's Abeta vaccination of rhesus monkeys (Macaca mulatta). Mechanisms of Ageing and Development, 125(2):149-151.

Gandy, S; DeMattos, R B; Lemere, C A; Heppner, F L; Leverone, J; Aguzzi, A; Ershler, W B; Dai, J; Fraser, P; Hyslop, P S; Holtzman, D M; Walker, L C; Keller, E T (2004). Alzheimer A beta vaccination of rhesus monkeys (Macaca mulatta). Alzheimer Disease and Associated Disorders, 18(1):44-46.

Heikenwalder, M; Prinz, M; Heppner, F L; Aguzzi, A (2004). Current concepts and controversies in prion immunopathology. Journal of Molecular Neuroscience, 23(1-2):3-12.

Prinz, M; Heikenwalder, M; Junt, T; Schwarz, Petra; Glatzel, M; Heppner, F L; Fu, Y X; Lipp, M; Aguzzi, A (2003). Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion. Nature, 425(6961):957-962.

Hutter, G; Heppner, F L; Aguzzi, A (2003). No superoxide dismutase activity of cellular prion protein in vivo. Biological Chemistry, 384(9):1279-1285.

Prinz, M; Huber, G; Macpherson, A J S; Heppner, F L; Glatzel, M; Eugster, H P; Wagner, N; Aguzzi, A (2003). Oral prion infection requires normal numbers of Peyer's patches but not of enteric lymphocytes. American Journal of Pathology, 162(4):1103-1111.

Aguzzi, A; Heppner, F L; Heikenwalder, M; Prinz, M; Mertz, K; Seeger, H; Glatzel, M (2003). Immune system and peripheral nerves in propagation of prions to CNS. British Medical Bulletin, 66(1):141-159.

Behrens, A; Genoud, N; Naumann, H; Rülicke, T J; Janett, F; Heppner, F L; Ledermann, B; Aguzzi, A (2002). Absence of the prion protein homologue Doppel causes male sterility. EMBO Journal, 21(14):3652-3658.

Heppner, F L; Aguzzi, A (2002). Immunität gegen Prionen? Deutsche Medizinische Wochenschrift, 127(7):328-330.

Heppner, F L; Musahl, C; Arrighi, I; Klein, M A; Rülicke, T; Oesch, B; Zinkernagel, R M; Kalinke, U; Aguzzi, A (2001). Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies. Science, 294(5540):178-182.

Aguzzi, A; Glatzel, M; Montrasio, F; Prinz, M; Heppner, F L (2001). Interventional strategies against prion diseases. Nature Reviews. Neuroscience, 2(10):745-749.

Glatzel, M; Heppner, F L; Albers, K M; Aguzzi, A (2001). Sympathetic innervation of lymphoreticular organs is rate limiting for prion neuroinvasion. Neuron, 31(1):25-34.

Heppner, F L; Arrighi, I; Kalinke, U; Aguzzi, A (2001). Immunity against prions? Trends in Molecular Medicine, 7(11):477-479.

Heppner, F L; Prinz, M; Aguzzi, A (2001). Pathogenesis of prion diseases: possible implications of microglial cells. Progress in Brain Research, 132:737-750.

Aguzzi, A; Brandner, S; Fischer, M B; Furukawa, H; Glatzel, M; Hawkins, C; Heppner, F L; Montrasio, F; Navarro, B; Parizek, P; Pekarik, V; Prinz, M; Raeber, A J; Röckl, C; Klein, M A (2001). Spongiform encephalopathies: insights from transgenic models. Advances in Virus Research, 56:313-352.

Heppner, F L; Christ, A D; Klein, M A; Prinz, M; Fried, M; Kraehenbuhl, J P; Aguzzi, A (2001). Transepithelial prion transport by M cells. Nature Medicine, 7(9):976-977.

Aguzzi, A; Heppner, F L (2000). Pathogenesis of prion diseases: a progress report. Cell Death and Differentiation, 7(10):889-902.

This list was generated on Wed Feb 21 16:39:36 2018 CET.